Page 6 - வீரியம் மிக்கது மனிதன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வீரியம் மிக்கது மனிதன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வீரியம் மிக்கது மனிதன் Today - Breaking & Trending Today

India sticks to AstraZeneca vaccine 'with full vigour'

India sticks to AstraZeneca vaccine 'with full vigour'
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Serum Institute , Astrazeneca Vaccine , Eu Countries , European Nations , World Health Organization , சீரம் நிறுவனம் , யூ நாடுகள் , ஐரோப்பிய நாடுகள் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,

Gilead, Merck collaborate to develop long-acting HIV treatment

Gilead and Merck will have an equal share in sales of the therapy until the revenue crosses certain milestones ....

Merck Co Inc , Gilead Sciences Inc , Gilead Sciences , Hiv Treatment , Wall Street Journal , மெர்க் இணை இன்க் , கிலியட் அறிவியல் இன்க் , கிலியட் அறிவியல் , எசைவீ சிகிச்சை , சுவர் தெரு இதழ் ,

Atea Pharmaceuticals Presents Favorable Phase 1 Results for AT-527 at 28th Annual Conference on Retroviruses and Opportunistic Infections

Data Supportive of AT-527 550 mg BID Dosing Regimen
BOSTON, March 06, 2021 (GLOBE NEWSWIRE) Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today presented results from the Phase 1 study of AT-527 in healthy volunteers at the 28th Annual Conference on Retroviruses and Opportunistic Infections (CROI) in a Science Spotlight presentation. AT-527 is an orally administered, direct-acting antiviral developmental agent derived from Atea’s purine nucleotide prodrug platform and is in Phase 2 clinical development for the treatment of COVID-19. AT-527 targets SARS-CoV-2 ribonucleic acid (RNA) polymerase (nsp12), a highly conserved gene which is responsible for both viral RNA replication and transcription. Given this preferential conserved target site, it is anticipated that the antiviral activity of AT-527 will continue even in the presence of naturally-evolving variants which are now emerging. ....

United States , Carol Guaccero , Jean Pierre Sommadossi , Jonae Barnes , Founder Of Atea Pharmaceuticals , Atea Pharmaceuticals , Corporate Communications , Atea Pharmaceuticals Inc , High Lung Levels , Active Triphosphate Predicted , Annual Conference , Opportunistic Infections , Science Spotlight , Chief Executive Officer , Investor Relations , Inc Stock Exchange , Press Release , Atea Avir , ஒன்றுபட்டது மாநிலங்களில் , பெருநிறுவன தகவல்தொடர்புகள் , உயர் நுரையீரல் நிலைகள் , ஆண்டு மாநாடு , அறிவியல் ஸ்பாட்லைட் , தலைமை நிர்வாகி அதிகாரி , முதலீட்டாளர் உறவுகள் , இன்க் ஸ்டாக் பரிமாற்றம் ,

Radically Improve Your Dosing Accuracy, Productivity, and Safety: The New XPR Automatic Balance

Today’s laboratories are handling higher throughput and smaller sample sizes than ever before. Click to read more. ....

Sen. Cornyn should vote for the best interests of the country

The sacking of the US Capitol on Jan. 6 was the most disturbing act of domestic terrorism I have ever witnessed. That the U.S. President would encourage his followers, who ....

Paul Ditullio , John Cornyn , Vice President , President Trump , Us Capitol , ஜான் கார்னி , துணை ப்ரெஸிடெஂட் , ப்ரெஸிடெஂட் துருப்பு , எங்களுக்கு கேபிடல் ,